Biosafety

Protein drugs, recombinant vaccines and cell therapy are among the fastest growing products in the biotech industry. It is important to ensure quality and safety of emerging biopharmaceutical or cellular products in addition to their efficacy. The mission of our group is to offer a consolidated testing service with the following features: 1. Global quality standards: International Conference on Harmonization (ICH), United States Food and Drug Administration (FDA), European Medicines Agency (EMEA) etc. 2. GLP quality systems: Compliance with GLP (Taiwan, FDA & OECD); Audit by qualified QA personnel for critical steps and procedures during each study 3. Quick response and timely delivery 4. Availability of customization


Wang, Sih-Rong

Wang, Sih-Rong

Reseacher Ph.D. National Tsing Hua University


Chang, Jen-Ting

Chang, Jen-Ting

QA Director M.S. National Taiwan University


Shih, Hsiao-Ling

Shih, Hsiao-Ling

TD Director M.S. Da-Yeh University


Shen, Chiu-Wen

Shen, Chiu-Wen

Quality Assurance M.S. National Chung Hsing University


Chen, Pei-Ying

Chen, Pei-Ying

Group Member M.S. National Chung Hsing University


Chen, Wei-Jie

Chen, Wei-Jie

Group Member M.S. National Chiao Tung University


Chen, Yi-Chun

Chen, Yi-Chun

Archivist B.S. National Chin-Yi University of Technology


Huang, Cheih-Wen

Huang, Cheih-Wen

Group Member M.S. National Chung Hsing University


Wu, Li-Ting

Wu, Li-Ting

Group Member M.S. National Cheng Kung University


Deng, Yu-Chiao

Deng, Yu-Chiao

Group Member M.S. National Chiayi University


Chung, Hui-yu

Chung, Hui-yu

Group Member M.S. National Chiao Tung University